D. J. PETTIBONE - Concepedia

Author

D. J. PETTIBONE

United States Military Academy

Also Known As

D PETTIBONE, D. J. PETTIBONE, D. J. Pettibone, D.J. Pettibone, Doug J. Pettibone, Doug Pettibone

Publications

468

Citations

H-Index

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)Vanderbilt University Medical Center

About

D. J. PETTIBONE is an author at United States Military Academy specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	432
2	Natural Sciences	6	6	373
3	Biochemistry	6	6	373
4	Social Sciences	3	3	37
5	Chemical Biology	2	2	91

D. J. PETTIBONE

Publications

432

Citations

H-Index

Page 1

	Year	Citations
Discovery of Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 5 from a Series of <i>N</i>-(1,3-Diphenyl-1<i>H</i>- pyrazol-5-yl)benzamides That Potentiate Receptor Function in Vivo Craig W. Lindsley, David D. Wisnoski, William Leister, Journal of Medicinal Chemistry Synaptic TransmissionPharmacotherapyActive Allosteric ModulatorsMolecular PharmacologyMedicinal Chemistry	2004	170
Development of an intact cell reporter gene β-lactamase assay for G protein-coupled receptors for high-throughput screening Priya Kunapuli, Richard W. Ransom, Kathy Murphy, Analytical Biochemistry Signal TransductionProtein ExpressionBiochemistryG Protein-coupled ReceptorNatural Sciences	2003	84
Challenges in the development of mGluR5 positive allosteric modulators: The discovery of CPPHA Zhijian Zhao, David D. Wisnoski, Julie A. O’Brien, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMolecular PhysiologySignal TransductionBiochemistryG Protein-coupled Receptor	2006	70
Discovery of GlyT1 inhibitors with improved pharmacokinetic properties S. E. Wolkenberg, Zhijian Zhao, David D. Wisnoski, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryGlyt1 InhibitorsMedicineGlycobiologyPharmacotherapy	2009	22
Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitors Zhijian Zhao, William Leister, Julie A. O’Brien, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryPotent Glyt1 InhibitorsBiochemistryMedicine	2009	21
Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides Zhijian Zhao, Julie A. O’Brien, Wei Lemaire, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ScienceGlyt1 InhibitorsBiochemistryMedicine	2006	18
A comparative electrophysiological and biochemical assessment of serotonin (5-HT) and a novel 5-HT agonist (MK-212) on central serotonergic receptors George G. Yarbrough, Dhirendra Singh, D. J. PETTIBONE Neuropharmacology Central Serotonergic ReceptorsBiochemical AssessmentNovel 5-Ht AgonistNeurophysiologyMedicine	1984	14
Dopamine agonist activity of EMD 23,448 G.E. Martin, D. J. PETTIBONE Journal of Neural Transmission Molecular PharmacologyDopamine Agonist ActivityMedicinePsychopharmacologyNeuropharmacology	1985	12
Heterogeneity of [3H]neurotensin binding: studies with dynorphin, L-156,903 and levocabastine D. J. PETTIBONE, James A. Totaro, Elbert E. Harris, Brain Research Molecular PharmacologyHypertensionMolecular NeuroscienceNeurophysiologyMedicine	1988	11
Recent Advances in the Development of Oxytocin Receptor Antagonists Paul Williams, D. J. PETTIBONE Current Pharmaceutical Design Medicinal ChemistryBiochemistryMedicineNatural SciencesPhysiology	1996	10

Page 1